4.7 Review

Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia

期刊

JOURNAL OF GASTROENTEROLOGY
卷 47, 期 8, 页码 862-871

出版社

SPRINGER JAPAN KK
DOI: 10.1007/s00535-012-0625-9

关键词

Functional gastrointestinal disorders; Visceral hypersensitivity; Abnormal gastric motility; Stress; Dyspepsia

资金

  1. Astra Zeneca Co Ltd.
  2. Daiichi Sankyo Co Ltd.
  3. Dainihon-Sumitomo Co Ltd.
  4. Takeda Pharmaceutical Co Ltd.
  5. Chugai Co Ltd.
  6. Yakult Co Ltd.

向作者/读者索取更多资源

Functional dyspepsia (FD), one of the most common conditions in medicine, is a gastrointestinal disorder in which the patient suffers from chronic dyspeptic symptoms such as epigastralgia and a heavy feeling in the stomach despite the absence of organic disease. Elucidating the pathogenesis of FD means answering the question, Why do symptoms occur? The factors contributing to symptom manifestation in FD probably should be divided into 3 categories: (1) physiological abnormalities that directly induce symptoms, (2) factors that modify those physiological abnormalities, and (3) factors that govern abnormal responses to stress. The symptoms of FD are directly caused by two major physiological abnormalities-abnormal gastric motility and visceral hypersensitivity-occurring in patients who have acquired excessive responsiveness to stress as a result of the environment during early life, genetic abnormalities, residual inflammation after gastrointestinal infections, or other causes, with the process modified by factors including psychophysiological abnormalities, abnormal secretion of gastric acid, Helicobacter pylori infection, diet, and lifestyle. If the basis of this model of FD pathogenesis is excessive responsiveness of gastrointestinal function to stress and external stimuli, psychosomatic approaches to alter stress perception could be important treatment options. However, in the primary care setting, the treatment of FD has focused on local gastric factors, including abnormal gastric acid secretion, abnormal gastric motility, and H. pylori infection. Acid secretion inhibitors and prokinetics have been commonly used, and H. pylori eradication therapy has been carried out, but the effectiveness of drug therapy has been limited.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据